Guillain–Barré syndrome (GBS) is an acute polyneuropathy mostly characterized by acute
flaccid paralysis with or without sensory/autonomous nerve dysfunction. Current immuno …

Guillain–Barre syndrome (GBS) is the leading cause of acute paralysis that can potentially
affect all of the human population. GBS is believed to be an immune-mediated disease …

Introduction: Up to 30% of patients with Guillain–Barré syndrome (GBS) develop respiratory
failure requiring intensive care unit (ICU) admission and mechanical ventilation. Progressive …

Abstract Introduction Guillain–Barré syndrome (GBS) is an acute, immune-mediated
polyneuropathy that often leads to severe weakness. Intravenous immunoglobulin (IVIG) is a …

Approximately one third of patients with Guillain-Barré syndrome (GBS) need to be admitted
to the intensive care unit (ICU) because of respiratory failure. A significant proportion of …

Guillain-Barré syndrome (GBS) is the most common cause of acute flaccid paralysis in the
developed world. Guillain-Barré syndrome typically presents with ascending paralysis and is …

Abstract Purpose of Review: This article reviews the current state of Guillain-Barré syndrome
(GBS), including its clinical presentation, evaluation, pathophysiology, and treatment …

Guillain-Barré syndrome is the most common and most severe acute paralytic neuropathy,
with about 100 000 people developing the disorder every year worldwide. Under the …

Guillain–Barré syndrome (GBS) is an acute polyradiculoneuropathy. Symptoms may vary
greatly in presentation and severity. Besides weakness and sensory disturbances, patients …

Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy with a highly variable
clinical course and outcome. Intravenous immunoglobulin (IVIg) and plasma exchange are …